A phase 1 open-label pilot study of low-dose interleukine-2 immunotherapy in patients with Alzheimer's disease

被引：10
|
作者：
Faridar, Alireza [1 ]
Eid, Abdulmunaim M. [1 ]
Thome, Aaron D. [1 ]
Zhao, Weihua [1 ]
Beers, David R. [1 ]
Pascual, Maria B. [1 ]
Nakawah, Mohammad O. [1 ]
Roman, Gustavo C. [1 ]
Davis, Charles S. [2 ]
Grundman, Michael [3 ,4 ]
Masdeu, Joseph C. [1 ]
Appel, Stanley H. [1 ]
机构：
[1] Houston Methodist Res Inst, Stanley H Appel Dept Neurol, 6565 Fannin St,Suite P3-201, Houston, TX 77030 USA
[2] CSD Biostat Inc, Oro Valley, AZ USA
[3] Global R&D Partners LLC, San Diego, CA USA
[4] Univ Calif San Diego, San Diego, CA USA
来源：
TRANSLATIONAL NEURODEGENERATION | 2023年 / 12卷 / 01期
关键词：
D O I：
10.1186/s40035-023-00387-5
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
Trial registrationClinicalTrials.gov Identifier: NCT05821153, Registered April 20 2023, Retrospectively registered, https://classic.clinicaltrials.gov/ct2/show/NCT05821153
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Induction of regulatory T cells and efficacy of low-dose interleukin-2 in systemic sclerosis: interventional open-label phase 1-phase 2a study
    Barde, Francois
    Lorenzon, Roberta
    Vicaut, Eric
    Riviere, Sebastien
    Cacoub, Patrice
    Cacciatore, Carlotta
    Rosenzwajg, Michelle
    Daguenel-Nguyen, Anne
    Fain, Olivier
    Klatzmann, David
    Mekinian, Arsene
    RMD OPEN, 2024, 10 (02):
  • [32] Efficacy of low-dose lung radiotherapy in the management of COVID-19 patients: a randomised, open-label study
    Dinakar, Kootala
    Jakka, Mohan Krishna
    Vemannagari, Pavan Kumar Reddy
    Mohan, Alladi
    Subramanian, Bala Venkat
    Bodagala, Vijayalakshmi Devi
    Bhuma, Vengamma
    Das, Pranabandhu
    Bonala, Sreenivasa Rao
    Vutukuru, Venkatarami Reddy
    BRITISH JOURNAL OF RADIOLOGY, 2023, 96 (1152):
  • [33] Open-label, dose-ranging pilot study of 4 weeks of low-dose therapy with sodium phosphate tablets in chronically constipated adults
    Medoff, J
    Katz, S
    Malik, P
    Pambianco, D
    Pruitt, R
    Poulos, J
    Rank, J
    Rose, M
    CLINICAL THERAPEUTICS, 2004, 26 (09) : 1479 - 1491
  • [34] Low-dose oral isotretinoin therapy in lichen planus pigmentosus: an open-label non-randomized prospective pilot study
    Muthu, Sendhil Kumaran
    Narang, Tarun
    Saikia, Uma N.
    Kanwar, Amrinder Jit
    Parsad, Davinder
    Dogra, Sunil
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2016, 55 (09) : 1048 - 1054
  • [35] A 2-year open-label study of galantamine therapy in Chinese Alzheimer's disease patients in Hong Kong
    Chu, L. W.
    Yik, P. Y.
    Mok, W.
    Chung, C. P.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2007, 61 (03) : 403 - 410
  • [36] An Open-Label, Multicenter Observational Study for Patients with Alzheimer's Disease Treated with Memantine in the Clinical Practice
    Stamouli, S. S.
    Tzanakaki, M.
    Giatas, S.
    Georgiadis, G.
    Papalexi, E.
    Parashos, I. A.
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA, 2011, 1 (01): : 10 - 19
  • [37] A 6-month open-label study of the effectiveness and tolerability of galantamine in patients with Alzheimer's disease
    Patterson, CE
    Passmore, AP
    Crawford, VLS
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2004, 58 (02) : 144 - 148
  • [38] Open-label flexible-dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease
    Friedman, Joseph H.
    Berman, Robert M.
    Goetz, Christopher G.
    Factor, Stewart A.
    Ondo, William G.
    Wojcieszek, Joanne
    Carson, William H.
    Marcus, Ronald N.
    MOVEMENT DISORDERS, 2006, 21 (12) : 2078 - 2081
  • [39] Bis-choline tetrathiomolybdate in patients with Wilson's disease: an open-label, multicentre, phase 2 study
    Weiss, Karl Heinz
    Askari, Frederick K.
    Czlonkowska, Anna
    Ferenci, Peter
    Bronstein, Jeff M.
    Bega, Danny
    Ala, Aftab
    Nicholl, David
    Flint, Susan
    Olsson, Lars
    Plitz, Thomas
    Bjartmar, Carl
    Schilsky, Michael L.
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2017, 2 (12): : 869 - 876
  • [40] A Phase 3 Randomized, Open-Label, Multicenter Study Comparing Isatuximab, Pomalidomide, and Low-Dose Dexamethasone Versus Pomalidomide and Low-Dose Dexamethasone in Patients with Relapsed / Multiple Myeloma Refractory (RRMM)
    Niederwieser, Dietger
    Richardson, Paul
    Attal, Michel
    Rajkumar, Vincent
    San-Miguel, Jesus
    Beksac, Meral
    Spicka, Ivan
    Leleu, Xavier
    Schjesvold, Fredrik
    Moreau, Philippe
    Dimopoulosu, Meletios
    Huan, Jeffrey Shang-Yi
    Minarik, Jiri
    Cavo, Michele
    Mace, Sandrine
    Prince, H. Miles
    Corzo, Kathryn P.
    Campana, Frank
    Le-Guennec, Solenn
    Dubin, Franck
    Anderson, Kenneth C.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 40 - 41
12345